{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:03:23Z","timestamp":1790388203114,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,3,3]],"date-time":"2018-03-03T00:00:00Z","timestamp":1520035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00261-018-1542-z","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T20:43:33Z","timestamp":1520023413000},"page":"2721-2727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["18F-FDG PET\/CT in splenic marginal zone lymphoma"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0810-6494","authenticated-orcid":false,"given":"Domenico","family":"Albano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Giubbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bertagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,3]]},"reference":[{"key":"1542_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-3-319-13150-4_9","volume":"165","author":"B Vannata","year":"2015","unstructured":"Vannata B, Stathis A, Zucca E (2015) Management of the marginal zone lymphomas. Cancer Treat Res 165:227\u2013249","journal-title":"Cancer Treat Res"},{"key":"1542_CR2","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","volume":"117","author":"E Campo","year":"2011","unstructured":"Campo E, Swerdlow SH, Harris NL, et al. (2011) The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 117:5019\u20135032","journal-title":"Blood"},{"key":"1542_CR3","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/annonc\/mds643","volume":"24","author":"M Dreyling","year":"2013","unstructured":"Dreyling M, Thieblemont C, Gallamini A, et al. (2013) ESMO Consensus conferences: guidelines on malignant lymphoma. Part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol 24:857\u2013877","journal-title":"Ann Oncol"},{"key":"1542_CR4","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1182\/blood-2002-07-2216","volume":"101","author":"V Franco","year":"2003","unstructured":"Franco V, Florena AM, Iannitto E (2003) Splenic marginal zone lymphoma. Blood 101:2464\u20132472","journal-title":"Blood"},{"key":"1542_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/sj.leu.2405068","volume":"22","author":"E Matutes","year":"2008","unstructured":"Matutes E, Oscier D, Montalban C, et al. (2008) Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia 22:487\u2013495","journal-title":"Leukemia"},{"key":"1542_CR6","first-page":"194","volume":"26","author":"C Thieblemont","year":"2012","unstructured":"Thieblemont C, Davi F, Noguera ME, et al. (2012) Splenic marginal zone lymphoma: current knowledge and future directions. Oncology 26:194\u2013202","journal-title":"Oncology"},{"key":"1542_CR7","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, et al. (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32:3059\u20133068","journal-title":"J Clin Oncol"},{"key":"1542_CR8","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","volume":"32","author":"SF Barrington","year":"2014","unstructured":"Barrington SF, Mikhaeel NG, Kostakoglu L (2014) Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 32:3048\u20133058","journal-title":"J Clin Oncol"},{"key":"1542_CR9","first-page":"5","volume":"4","author":"BD Cheson","year":"2015","unstructured":"Cheson BD (2015) Staging and response assessment in lymphomas: the new Lugano classification. Chin Clin Oncol 4:5","journal-title":"Chin Clin Oncol"},{"key":"1542_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/hon.2152","volume":"33","author":"G Treglia","year":"2015","unstructured":"Treglia G, Zucca E, Sadeghi R, et al. (2015) Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta-analysis. Hematol Oncol 33:113\u2013124","journal-title":"Hematol Oncol"},{"key":"1542_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4166\/kjg.2016.67.4.183","volume":"67","author":"JW Hwang","year":"2016","unstructured":"Hwang JW, Jee SR, Lee SH, et al. (2016) Efficacy of positron emission tomography\/computed tomography in gastric mucosa-associated lymphoid tissue lymphoma. Korean J Gastroenterol 67:183\u2013188","journal-title":"Korean J Gastroenterol"},{"issue":"90","key":"1542_CR12","first-page":"20170311","volume":"2017","author":"D Albano","year":"1079","unstructured":"Albano D, Borghesi A, Bosio G, et al. (1079) Pulmonary mucosa-associated lymphoid tissue lymphoma: 18F-FDG PET\/CT and CT findings in 28 patients. Br J Radiol 2017(90):20170311","journal-title":"Br J Radiol"},{"issue":"12","key":"1542_CR13","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.3109\/10428194.2015.1030640","volume":"56","author":"SH Park","year":"2015","unstructured":"Park SH, Lee JJ, Kim HO, et al. (2015) 18F-Fluorodeoxyglucose (FDG)-positron emission tomography\/computed tomography in mucosa-associated lymphoid tissue lymphoma: variation in 18F-FDG avidity according to site involvement. Leuk Lymphoma 56(12):3288\u20133294","journal-title":"Leuk Lymphoma"},{"key":"1542_CR14","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1007\/s00261-016-0800-1","volume":"41","author":"D Albano","year":"2016","unstructured":"Albano D, Giubbini R, Bertagna F (2016) 18F-FDG PET\/CT and primary hepatic MALT: a case series. Abdom Radiol 41:1956\u20131959","journal-title":"Abdom Radiol"},{"key":"1542_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2376","author":"D Albano","year":"2016","unstructured":"Albano D, Bosio G, Orlando E, Bertagna F (2016) Role of fluorine-18-fluorodeoxyglucose positron emission tomography\/computed tomography in evaluating breast mucosa-associated lymphoid tissue lymphoma: a case series. Hematol Oncol . \n                    https:\/\/doi.org\/10.1002\/hon.2376","journal-title":"Hematol Oncol"},{"key":"1542_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00259-016-3518-y","volume":"44","author":"D Albano","year":"2017","unstructured":"Albano D, Bertoli M, Ferro P, et al. (2017) 18F-FDG PET\/CT in gastric MALT lymphoma: a bicentric experience. Eur J Nucl Med Mol Imaging 44:589\u2013597","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1542_CR17","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1093\/annonc\/mdl295","volume":"17","author":"M Hoffmann","year":"2006","unstructured":"Hoffmann M, W\u00f6hrer S, Becherer A, et al. (2006) 18F-Fluoro-deoxyglucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference. Ann Oncol 17:1761\u20131765","journal-title":"Ann Oncol"},{"key":"1542_CR18","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1080\/10428194.2017.1298754","volume":"58","author":"D Albano","year":"2017","unstructured":"Albano D, Bosio G, Giubbini R, Bertagna F (2017) 18F-FDG PET\/CT and extragastric MALT lymphoma: role of Ki-67 score and plasmacytic differentiation. Leuk Lymphoma 58:2328\u20132334","journal-title":"Leuk Lymphoma"},{"key":"1542_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2967\/jnumed.109.067892","volume":"51","author":"M Weiler-Sagie","year":"2010","unstructured":"Weiler-Sagie M, Bushelev O, Epelbaum R, et al. (2010) (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients. J Nucl Med 51:25\u201330","journal-title":"J Nucl Med"},{"key":"1542_CR20","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/cncr.22807","volume":"110","author":"N Tsukamoto","year":"2007","unstructured":"Tsukamoto N, Kojima M, Hasegawa M, et al. (2007) The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification. Cancer 110:652\u2013659","journal-title":"Cancer"},{"issue":"4","key":"1542_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/hon.2181","volume":"33","author":"E Carrillo-Cruz","year":"2015","unstructured":"Carrillo-Cruz E, Marin-Oyaga V, de la Cruz Vicente F, et al. (2015) Role of 18F-FDG-PET\/CT in the management of marginal zone B cell lymphoma. Hematol Oncol 33(4):151\u2013158","journal-title":"Hematol Oncol"},{"key":"1542_CR22","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1182\/blood-2015-11-624312","volume":"127","author":"L Arcaini","year":"2016","unstructured":"Arcaini L, Rossi D, Paulli M (2016) Splenic marginal zone lymphoma: from genetics to management. Blood 127:2072\u20132081","journal-title":"Blood"},{"key":"1542_CR23","first-page":"286","volume":"79","author":"PG Gobbi","year":"1994","unstructured":"Gobbi PG, Grignani GE, Pozzetti U, et al. (1994) Primary splenic lymphoma: does it exist? Haematologica 79:286\u2013293","journal-title":"Haematologica"},{"key":"1542_CR24","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s00277-003-0631-3","volume":"82","author":"U Rueffer","year":"2003","unstructured":"Rueffer U, Sieber M, Stemberg M, et al. (2003) Spleen involvement in Hodgkin\u2019s lymphoma: assessment and risk profile. Ann Hematol 82:390\u2013396","journal-title":"Ann Hematol"},{"key":"1542_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejrad.2007.02.011","volume":"64","author":"M Kang","year":"2007","unstructured":"Kang M, Kalra N, Gulati M, et al. (2007) Image guided percutaneous splenic interventions. Eur J Radiol 64:140\u2013146","journal-title":"Eur J Radiol"},{"key":"1542_CR26","first-page":"1072","volume":"44","author":"JN Rini","year":"2003","unstructured":"Rini JN, Leonidas JC, Tomas MB, et al. (2003) 18F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma. J Nucl Med 44:1072\u20131074","journal-title":"J Nucl Med"},{"key":"1542_CR27","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2214\/AJR.08.1160","volume":"192","author":"PA Jong de","year":"2009","unstructured":"de Jong PA, van Ufford HM, Baarslag HJ, et al. (2009) CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma. AJR Am J Roentgenol 192:745\u2013753","journal-title":"AJR Am J Roentgenol"},{"key":"1542_CR28","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1097\/RLU.0000000000000523","volume":"39","author":"S Karunanithi","year":"2014","unstructured":"Karunanithi S, Sharma P, Guha SR, et al. (2014) Use of 18F-FDG PET\/CT imaging for evaluation of patients with primary splenic lymphoma. Clin Nucl Med 39:772\u2013776","journal-title":"Clin Nucl Med"},{"key":"1542_CR29","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/00003072-200208000-00005","volume":"27","author":"J Rini","year":"2002","unstructured":"Rini J, Manalili EY, Hoffman MA, et al. (2002) F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin\u2019s disease. Clin Nucl Med 27:572\u2013577","journal-title":"Clin Nucl Med"},{"key":"1542_CR30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1053\/j.semnuclmed.2007.02.001","volume":"37","author":"JM Meier","year":"2007","unstructured":"Meier JM, Alavi A, Iruvuri S, et al. (2007) Assessment of age-related changes in abdominal organ structure and function with computed tomography and positron emission tomography. Semin Nucl Med 37:154\u2013172","journal-title":"Semin Nucl Med"},{"key":"1542_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s002590050356","volume":"26","author":"J Kotzerke","year":"1999","unstructured":"Kotzerke J, Guhlmann A, Moog F, et al. (1999) Role of attenuation correction for fluorine-18-fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma. Eur J Nucl Med 26:31\u201338","journal-title":"Eur J Nucl Med"},{"key":"1542_CR32","first-page":"867","volume":"138","author":"J Gerdes","year":"1991","unstructured":"Gerdes J, Li L, Schlueter C, et al. (1991) Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138:867\u2013873","journal-title":"Am J Pathol"},{"key":"1542_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s12185-012-1225-4","volume":"97","author":"Y Watanabe","year":"2013","unstructured":"Watanabe Y, Suefuji H, Hirose Y, et al. (2013) 18F-FDG uptake in primary gastric malignant lymphoma correlates with glucose transporter 1 expression and histologic malignant potential. Int J Hematol 97:43\u201349","journal-title":"Int J Hematol"},{"key":"1542_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1309\/AJCP63OGXHXCSKSC","volume":"136","author":"TJ Molina","year":"2011","unstructured":"Molina TJ, Lin P, Swerdlow S, et al. (2011) Marginal zone lymphomas with plasmacytic differentiation and related disorders. Am J Clin Pathol 136:211\u2013225","journal-title":"Am J Clin Pathol"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00261-018-1542-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-018-1542-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-018-1542-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T19:30:31Z","timestamp":1551555031000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00261-018-1542-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,3]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1542"],"URL":"https:\/\/doi.org\/10.1007\/s00261-018-1542-z","relation":{},"ISSN":["2366-004X","2366-0058"],"issn-type":[{"value":"2366-004X","type":"print"},{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,3]]},"assertion":[{"value":"3 March 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participant included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}